|
Volumn 72, Issue 24, 2015, Pages 2125-
|
Mepolizumab approved as add-on long-term therapy for severe asthma
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
MEPOLIZUMAB;
MONOCLONAL ANTIBODY;
ASTHMA;
BLOOD;
COMBINATION DRUG THERAPY;
HUMAN;
SEVERITY OF ILLNESS INDEX;
ANTI-ASTHMATIC AGENTS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ASTHMA;
DRUG THERAPY, COMBINATION;
HUMANS;
SEVERITY OF ILLNESS INDEX;
|
EID: 84987940027
PISSN: None
EISSN: 15352900
Source Type: Journal
DOI: 10.2146/news150083 Document Type: Note |
Times cited : (7)
|
References (0)
|